Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.960
-0.070 (-2.31%)
At close: Sep 18, 2026, 4:00 PM EDT
2.970
+0.010 (0.34%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Entera Bio Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Entera Bio stock have an average target of $9.00, which predicts a 204.05% increase from the current stock price of 2.96.

Price Target: $9.00 (+204.05%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$9.00$9.00$9.00$9.00
Change+204.05%+204.05%+204.05%+204.05%

Analyst Ratings

The average analyst rating for Entera Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Sep '26
Strong Buy111112
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Initiates
$9
BuyInitiates$9+204.05%Sep 18, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$9
BuyReiterates$9+204.05%Jun 24, 2026

Financial Forecast

Revenue This Year
n/a
from 42.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
571.00K134.00K-181.00K42.00K-
Revenue Growth
56.44%-76.53%---76.80%-100.00%
Operating Income
-12.22M-13.47M-8.89M-9.59M-11.53M-19.54M
Net Income
-12.19M-13.07M-8.89M-9.54M-11.44M-24.80M
Free Cash Flow
-----96.81M
No. Analysts
-----2

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-100.0%
Avg
-100.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-